791
Views
12
CrossRef citations to date
0
Altmetric
Review

Pharmacological treatment for insomnia in patients with major depressive disorder

, , &
Pages 1341-1349 | Received 23 Jan 2019, Accepted 30 Apr 2019, Published online: 16 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jian-Xiong An, John P Williams, Qi-Wu Fang, Yong Wang, Hui Liu, Le Shi & Wen-Hao Zhang. (2020) Feasibility of Patient-Controlled Sleep with Dexmedetomidine in Treating Chronic Intractable Insomnia. Nature and Science of Sleep 12, pages 1033-1042.
Read now

Articles from other publishers (11)

Mingxie Ni, Meng Zheng, Bingran Chen, Xu Lu, Hui Zhao, Tao Zhu, Li Cheng, Han Han, Ting Ye, Huijun Liu, Ying Ye, Chao Huang & Xiaomei Yuan. (2023) Microglial stimulation triggered by intranasal lipopolysaccharide administration produces antidepressant-like effect through ERK1/2-mediated BDNF synthesis in the hippocampus. Neuropharmacology 240, pages 109693.
Crossref
Meng Zheng, Tao Zhu, Bingran Chen, Hui Zhao, Xu Lu, Qun Lu, Mingxie Ni, Li Cheng, Han Han, Ting Ye, Ying Ye, Huijun Liu & Chao Huang. (2023) Intranasal Monophosphoryl Lipid a Administration Ameliorates depression-like Behavior in Chronically Stressed Mice Through Stimulation of Microglia. Neurochemical Research 48:10, pages 3160-3176.
Crossref
Chao Huang, Ting Ye, Bingran Chen, Zhuo Chen, Ying Ye & Huijun Liu. (2023) Intranasal administration of lipopolysaccharide reverses chronic stress-induced depression-like behavior in mice by microglial stimulation. International Immunopharmacology 120, pages 110347.
Crossref
Guohong Xu, Xiaoling Li, Caixia Xu, Guojun Xie & Jiaquan Liang. (2022) Effect of insomnia in the major depressive disorder. BMC Neurology 22:1.
Crossref
Fu Li, Xu Lu, Yaoying Ma, Yue Gu, Ting Ye & Chao Huang. (2022) Monophosphoryl Lipid A Tolerance Against Chronic Stress-Induced Depression-Like Behaviors in Mice. International Journal of Neuropsychopharmacology 25:5, pages 399-411.
Crossref
Michael P. Hengartner, Stefan Neuner-Jehle & Oliver Senn. (2021) Swiss GPs’ preferences for antidepressant treatment in mild depression: vignette-based quantitative analysis. BMC Family Practice 22:1.
Crossref
Elisa M. Brietzke, Rodrigo B. Mansur, Fabiano A. Gomes & Roger S. McIntyre. 2021. Ketamine for Treatment-Resistant Depression. Ketamine for Treatment-Resistant Depression 139 146 .
Yue Gu, Ting Ye, Pingping Tan, Lijuan Tong, Jianlin Ji, Yiming Gu, Zhongxia Shen, Xinhua Shen, Xu Lu & Chao Huang. (2020) Tolerance-inducing effect and properties of innate immune stimulation on chronic stress-induced behavioral abnormalities in mice. Brain, Behavior, and Immunity.
Crossref
Manfred Klöbl, Gregor Gryglewski, Lucas Rischka, Godber Mathis Godbersen, Jakob Unterholzner, Murray Bruce Reed, Paul Michenthaler, Thomas Vanicek, Edda Winkler-Pjrek, Andreas Hahn, Siegfried Kasper & Rupert Lanzenberger. (2020) Predicting Antidepressant Citalopram Treatment Response via Changes in Brain Functional Connectivity After Acute Intravenous Challenge. Frontiers in Computational Neuroscience 14.
Crossref
Tsung-Hua Lu, PoSee Chen, KaoChin Chen, IHui Lee & YenKuang Yang. (2020) Poor sleep in medicated patients with remitted depressive disorder: A naturalistic study. Taiwanese Journal of Psychiatry 34:1, pages 42.
Crossref
Naaz Kapadia, Vera Zivanovic, Bastien Moineau, Jonathan Downar, Jose Zariffa & Milos R. Popovic. (2019) Functional electrical stimulation of the facial muscles to improve symptoms in individuals with major depressive disorder: pilot feasibility study. BioMedical Engineering OnLine 18:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.